Literature DB >> 11448369

Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.

S D Martin1, E Martin, S S Rai, M A Richardson, R Royall.   

Abstract

BACKGROUND: Functional brain imaging studies in major depression have suggested abnormalities of areas, including the frontal cortex, cingulate gyrus, basal ganglia, and temporal cortex. We hypothesized that venlafaxine hydrochloride and interpersonal psychotherapy (IPT) might each alter brain blood flow in some or all of these areas on sequential single photon emission computed tomography (SPECT) scans.
METHODS: Twenty-eight men and women aged 30 to 53 years with a DSM-IV major depressive episode, a 17-item Hamilton Rating Scale for Depression (HAM-D) rating of 18 or higher, and antidepressant-naive for at least 6 months were studied. After baseline (99m)technetium-hexa-methyl-propylene-amine-oxime scan, 1-T magnetic resonance imaging, and psychometric ratings, patients were assigned to different treatments. Thirteen patients had 1-hour weekly sessions of IPT from the same supervised therapist (E.M.). Fifteen patients took 37.5 mg twice-daily of venlafaxine hydrochloride. Single-photon emission computed tomography scans and ratings were repeated at 6 weeks.
RESULTS: Both treatment groups improved substantially, more so with venlafaxine (mean [SD] HAM-D scores at pretreatment: IPT, 22.7 [2.7], and venlafaxine, 22.4 [3.1]; and posttreatment: IPT, 16.2 [7.1], and venlafaxine, 10.9 [8.6]). No patients had structural brain abnormalities. On analysis with statistical parametric mapping 96, the venlafaxine group showed right posterior temporal and right basal ganglia activation (P =.01), while the IPT group had limbic right posterior cingulate and right basal ganglia activation (P =.01).
CONCLUSIONS: This preliminary investigation has shown limbic blood flow increase with IPT yet not venlafaxine, while both treatments demonstrated increased basal ganglia blood flow. This was, however, a short trial with a small sample, no control group, and different symptom reduction in the 2 groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448369     DOI: 10.1001/archpsyc.58.7.641

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  50 in total

1.  Interpersonal psychotherapy: principles and applications.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

2.  Functional neuroimaging in mental disorders.

Authors:  Philip K McGuire; Kazunori Matsumoto
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

Review 3.  Targeted electrode-based modulation of neural circuits for depression.

Authors:  Helen S Mayberg
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

Review 4.  Neuropsychotherapy: conceptual, empirical and neuroethical issues.

Authors:  Henrik Walter; Mathias Berger; Knut Schnell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

5.  The functional neuroanatomy of geriatric depression.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Peter Kingsley; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

Review 6.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

7.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

8.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

9.  Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression.

Authors:  Wei He; Hao Chai; Yingchun Zhang; Shaohua Yu; Wei Chen; Wei Wang
Journal:  Int J Med Sci       Date:  2010-07-02       Impact factor: 3.738

10.  Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

Authors:  Matthew P Ward; Pedro P Irazoqui
Journal:  Front Neuroeng       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.